How might cost effectiveness, quality of life, and outcomes data be used by government regulators?
B
B
Gatty
D003362:Cost-Benefit Analysis; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D018166:Health Care Reform / Q000331:legislation & jurisprudence*; D017063:Outcome Assessment, Health Care; D011788:Quality of Life; D014481:United States; D014486:United States Food and Drug Administration